General Information of the Compound
Compound ID
CP0405521
Compound Name
(2S)-2-[[(2S)-2-[[(2S,5R,8S,11S,19R)-19-[[(2S)-4-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-4-(diaminomethylideneamino)butanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-oxobutanoyl]amino]-2-[(2S)-butan-2-yl]-8-[3-(diaminomethylideneamino)propyl]-5-[(1R)-1-hydroxyethyl]-3,6,9,14,20-pentaoxo-1,4,7,10,15-pentazacycloicosane-11-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid
    Show/Hide
Structure
Formula
C110H167N35O28
Molecular Weight
2427.763
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]1CCCNC(=O)CC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](NC(=O)[C@@H](NC1=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
    Show/Hide
InChI
InChI=1S/C110H167N35O28/c1-10-55(5)85(103(169)140-80(50-83(112)152)100(166)131-72-16-12-39-122-84(153)37-36-73(93(159)130-70(18-14-41-124-108(115)116)92(158)141-81(106(172)173)48-63-26-34-68(151)35-27-63)132-90(156)71(19-15-42-125-109(117)118)134-105(171)87(59(9)147)145-104(170)86(56(6)11-2)143-95(72)161)144-101(167)78(47-62-24-32-67(150)33-25-62)138-99(165)79(49-64-51-121-53-127-64)139-94(160)74(38-43-126-110(119)120)133-96(162)75(44-54(3)4)135-89(155)58(8)128-102(168)82(52-146)142-98(164)77(46-61-22-30-66(149)31-23-61)137-97(163)76(45-60-20-28-65(148)29-21-60)136-91(157)69(129-88(154)57(7)111)17-13-40-123-107(113)114/h20-35,51,53-59,69-82,85-87,146-151H,10-19,36-50,52,111H2,1-9H3,(H2,112,152)(H,121,127)(H,122,153)(H,128,168)(H,129,154)(H,130,159)(H,131,166)(H,132,156)(H,133,162)(H,134,171)(H,135,155)(H,136,157)(H,137,163)(H,138,165)(H,139,160)(H,140,169)(H,141,158)(H,142,164)(H,143,161)(H,144,167)(H,145,170)(H,172,173)(H4,113,114,123)(H4,115,116,124)(H4,117,118,125)(H4,119,120,126)/t55-,56-,57-,58-,59+,69-,70-,71-,72+,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,85-,86-,87+/m0/s1
    Show/Hide
InChIKey
IRLXEZIEHOYDEE-FXDHAGSHSA-N
Physicochemical Property
logP
-9.33652
Rotatable Bonds
64
Heavy Atom Count
173
Polar Areas
1056.97
Hydrogen Bond Donor Count
41
Hydrogen Bond Acceptor Count
33
Complexity
173

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44346929
ChEMBL ID
CHEMBL425080
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02259, Neuropeptide Y receptor type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000074 SK-N-MC Homo sapiens (Human)  1
1
Kd > 1000 nM
   TI
   LI
   LO
   TS
Protein ID: PT01611, Neuropeptide Y receptor type 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000636 SK-N-BE(1) Homo sapiens (Human)  1
1
Kd = 950 nM
   TI
   LI
   LO
   TS